Nach Genre filtern

Oncology Today with Dr Neil Love

Oncology Today with Dr Neil Love

Dr. Neil Love

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

702 - Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on the Utility of Tafasitamab
0:00 / 0:00
1x
  • 702 - Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on the Utility of Tafasitamab

    Featuring an interview with Dr Matthew Lunning, including the following topics:

    Tafasitamab for follicular lymphoma (0:00)frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51)

    CME information and select publications

    Mon, 16 Nov 2026 - 15min
  • 701 - Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies

    Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics:

    Introduction (0:00)Prologue: Saturday Night Fever (1:35)Baby Boomers' Guide to Mechanisms of Action (3:07)Second-Line Treatment (12:36)Complications Associated with Bispecific Antibodies (23:41)Case Presentations (25:52)New Bispecific T-Cell Engagers — Surovatamig (26:24)Other Novel Agents (50:05)

    CME information and select publications

    Fri, 13 Nov 2026 - 57min
  • 700 - Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

    Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics:

    Multiple Myeloma (0:00)Introduction: ESMO 2026; Recent FDA Approvals (1:53)Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46)Bispecific Antibodies — Dr Lonial (19:16)Antibody-Drug Conjugates — Dr Richardson (37:08)Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10)

    CME information and select publications

    Wed, 11 Nov 2026 - 1h 02min
  • 699 - Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

    Featuring perspectives from Dr Neeraj Agarwal and Dr Emmanuel S Antonarakis, including the following topics:

    Introduction: ESMO 2026; Recent FDA Approvals (0:00)Selection of Endocrine Therapy — Dr Antonarakis (2:24)Utility of PARP Inhibitors — Dr Agarwal (22:59)AKT Inhibition for PTEN-Deficient Disease — Dr Antonarakis (35:42)Radiopharmaceuticals — Dr Agarwal (45:02)

    CME information and select publications

    Tue, 10 Nov 2026 - 58min
  • 698 - Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

    Featuring perspectives from Dr Charles E Geyer Jr, Dr Maryam Lustberg, Dr Rita Nanda and Dr Seth Wander, including the following topics:

    Breast Cancer Introduction: ESMO 2026; Recent FDA Approvals (0:00)ER-Positive Breast Cancer (5:01)HER2-Positive Breast Cancer (1:19:08)Triple-Negative Breast Cancer (1:48:54)

    CME information and select publications

    Mon, 09 Nov 2026 - 2h 22min
Weitere Folgen anzeigen